Difference between revisions of "Leadership"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[checked revision][checked revision]
Line 2: Line 2:
  
 
[[File:Jennelle Hodge photo cropped.jpg|center|thumb|Jennelle C. Hodge, PhD, FACMG, Associate Professor, Department of Medical and Molecular Genetics, Indiana University; '''[mailto:jhodge1@iu.edu <u>jhodge1@iu.edu</u>]'''; '''Editor-in-Chief CCGA''']]
 
[[File:Jennelle Hodge photo cropped.jpg|center|thumb|Jennelle C. Hodge, PhD, FACMG, Associate Professor, Department of Medical and Molecular Genetics, Indiana University; '''[mailto:jhodge1@iu.edu <u>jhodge1@iu.edu</u>]'''; '''Editor-in-Chief CCGA''']]
 +
 +
[[File:Krysiak_Kilannin.jpg|center|thumb|Kilannin Krysiak, PhD, Assistant Professor, Department of Pathology and Immunology, Washington University School of Medicine; '''[mailto:kkrysiak@wustl.edu <u>kkrysiak@wustl.edu</u>]'''; '''Technical Editor CCGA''']]
  
 
[[File:Fabiola-Quintero Riviera-orig 2019.jpg|center|thumb|Fabiola-Quintero-Rivera, MD, Professor, Departments of Pathology and Laboratory Medicine and Pediatrics, University of California Irvine; '''[mailto:fabiolaq@hs.uci.edu<u>fabiolaq@hs.uci.edu</u>]'''; '''Associate Editor CCGA [MDS/MPN Section]''']]
 
[[File:Fabiola-Quintero Riviera-orig 2019.jpg|center|thumb|Fabiola-Quintero-Rivera, MD, Professor, Departments of Pathology and Laboratory Medicine and Pediatrics, University of California Irvine; '''[mailto:fabiolaq@hs.uci.edu<u>fabiolaq@hs.uci.edu</u>]'''; '''Associate Editor CCGA [MDS/MPN Section]''']]

Revision as of 14:48, 25 September 2021

Meet your editors! We welcome questions and your participation in the CCGA.

Jennelle C. Hodge, PhD, FACMG, Associate Professor, Department of Medical and Molecular Genetics, Indiana University; jhodge1@iu.edu; Editor-in-Chief CCGA
Kilannin Krysiak, PhD, Assistant Professor, Department of Pathology and Immunology, Washington University School of Medicine; kkrysiak@wustl.edu; Technical Editor CCGA
Fabiola-Quintero-Rivera, MD, Professor, Departments of Pathology and Laboratory Medicine and Pediatrics, University of California Irvine; fabiolaq@hs.uci.edu; Associate Editor CCGA [MDS/MPN Section]
Yassmine Akkari, PhD, FACMG, Scientific Director of Cytogenetics and Molecular Pathology, Manager of Genetics Laboratories Operations, Legacy Health; YAkkari@LHS.ORG; Associate Editor CCGA [ALL Section]
Snehal Patel, MD, PhD; sbpatel2009@gmail.com; Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Mature T- and NK-cell Neoplasms Section]
Greg Corboy, PhD, Pathology Queensland (Queensland, Australia) School of Clinical Sciences, Monash University (Melbourne, Australia), Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia); gregcorboy@bigpond.com; Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Hodgkin Lymphomas/Lymphoproliferative Disorders/Other Rare Entities Section]
Malini Sathanoori, PhD, FACMG, Associate Director, Clinical Cytogenetics, FISH and Microarray Services, PathGroup; MSathanoori@pathgroup.com; Associate Editor CCGA [AML Section]
Alanna Church, MSc, MD, FRCPC, Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP), Boston Children’s Hospital, Assistant Professor of Pathology, Harvard Medical School; Alanna.Church@childrens.harvard.edu; Associate Editor CCGA [Gene-Specific Section]